EVTV Board of Directors Approves Amended and Restated LOI with AZIO AI at $3.00 Per Share, Subject to Independent Third-Party Valuation ...
Try SAM 3D to create editable 3D models and meshes from images, with manual scale and rotate tools, helping beginners turn ...
Gilgamesh Pharma, a clinical-stage neuroscience company focused on transforming psychiatric treatment, today announced positive topline results from its Phase 2a study of blixeprodil (GM-1020).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback